In contrast, the ApcMin/+ mouse model, in which the development of intestinal tumors depends primarily on genetic alterations in epithelial cells rather than inflammation, showed the impaired occurrence and growth of intestinal tumors due to the loss of RBBP9. This evidence concerns the gene RBBP9 and intestinal neoplasm.